Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0562 per EA under NDC 67877046805. Its NADAC has been published 231 times since Mar 23, 2022.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 225 MG CAPSULE

Pregabalin
$0.0562per EA
DEA Schedule CV

Strength

225 mg/1

NDC

67877046805

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA207799

FDA Approved

7/19/2019

TE Code

AB

On Market Since

7/21/2019

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0562 per EA
All-time high$0.1239 (Apr 13, 2022)
All-time low$0.0529 (Nov 20, 2024)
52-week high$0.0702
52-week low$0.0543
Median price$0.0732
Average price$0.0775
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked231
Tracking sinceMar 23, 2022

Price History

1W

+3.5%

1M

+1.2%

3M

+1.1%

6M

-7.6%

1Y

-18.4%

3Y

-34.7%

5Y

N/A

All

-54.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0562 per EA (NDC 67877046805), effective Aug 19, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 54.7%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Mar 23, 2022, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.1239 (Apr 13, 2022), with a median of $0.0732 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 225 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 67877046805) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.